Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2007
08/09/2007DE102005062144A1 Ingwerfraktion zur Inhibierung humaner CYP Enzyme Ginger Group for inhibiting human CYP enzymes
08/09/2007DE102005033903B4 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them
08/09/2007DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome
08/09/2007CA2640454A1 Compounds and methods for modulating protein trafficking
08/08/2007EP1816205A1 Serotype of adenovirus and uses thereof
08/08/2007EP1816204A1 Recombinant Adenovirus of the Ad26 serotype
08/08/2007EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists
08/08/2007EP1816122A2 3,4,5-substituted piperidines as therapeutic compounds
08/08/2007EP1815868A2 Drug absorptivity improving agent
08/08/2007EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system
08/08/2007EP1814915A1 Neutralising antibody molecules having specificity for human il-17
08/08/2007EP1814857A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
08/08/2007EP1814577A2 Use of baff to treat sepsis
08/08/2007EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007EP1487832B1 Micronized crystalline tiotropium bromide
08/08/2007EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
08/08/2007EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
08/08/2007EP1381387B1 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
08/08/2007EP1370233B1 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound
08/08/2007EP1360169B1 Succinate salt of o-desmethyl-venlafaxine
08/08/2007EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage
08/08/2007EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
08/08/2007EP1323712B1 Process for producing multiform crystal of donepezil hydrochloride
08/08/2007EP1315509B1 Nitrogen oxide for use in the treatment of drug resistant organisms
08/08/2007EP1277736B1 Novel bicyclic compounds
08/08/2007EP1267616B1 Methods of increasing hair growth by wnt polypeptide
08/08/2007EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/08/2007EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
08/08/2007EP1039804A4 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
08/08/2007EP0837129B1 Epimorphin antagonist and process for producing the same
08/08/2007CN1330765C Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
08/08/2007CN1330754C Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/08/2007CN1330748C Bacterial protection
08/08/2007CN1330671C Chitosan-containing polysaccharide, method for preparing the same and use thereof
08/08/2007CN1330661C Derivatives of monosaccharides for drug discovery
08/08/2007CN1330654C Fused bicyclic pyrimidine derivatives
08/08/2007CN1330641C Activator for peroxisome proliferator-responsive receptor delta
08/08/2007CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/08/2007CN1330639C Crystalline pharmaceutical
08/08/2007CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/08/2007CN1330633C Pyrrolidine derivatives as oxytocin antagonists
08/08/2007CN1330632C 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same
08/08/2007CN1330385C Gypsum bandage immersion liquid, its making method and use
08/08/2007CN1330375C Humanized antibodies that recognize verotoxin II and cell line producing same
08/08/2007CN1330347C Gongbu ointment
08/08/2007CN1330309C Preventives or remedies for diseases caused by e NOS expression
08/08/2007CN1330303C Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/08/2007CN1330256C Propolis honey sweets and preparation process
08/08/2007CN101014595A Novel cyclic aminobenzoic acid derivative
08/08/2007CN101014332A Agent for treatment of keratoconjunctive disorder
08/08/2007CN101012259A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
08/08/2007CN101012211A Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof
08/08/2007CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
08/08/2007CN101011584A Method for achieving persistent transgene expression
08/08/2007CN101011583A Gene medicament for promoting mink growth
08/08/2007CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
08/08/2007CN101011573A Production of high molecular mass lectins
08/08/2007CN101011555A Chinese medicine preparation for treating radioactive fibrosis and its preparation process
08/08/2007CN101011472A Medicine with blood vessel filling function
08/08/2007CN101011432A Use of extract of bracken flavone as medicament for lead expelling and lead poisioning alleviation
08/08/2007CN101011391A Clonidine paster for treating children's hyperkinetic symptom, twitch symptom and its preparation method
08/08/2007CN101011118A Infant nutrient honey and processing method thereof
08/08/2007CN101011109A Asterias poultry feed additive
08/08/2007CN101011107A Pharmaceutical premixed agent for disease resistance and growth promotion and application thereof
08/08/2007CN101011097A Herb tea compositions
08/08/2007CN101011096A Hubei Malus spectabilis tea
08/08/2007CN101011095A Megranate tea and its preparing process
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253284 Chemical compounds
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
08/07/2007US7253188 Aminobenzamide derivative
08/07/2007US7253187 Heterocyclic inhibitors of ERK2 and uses thereof
08/07/2007US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
08/07/2007US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation
08/07/2007US7253178 Carboxylic acids
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253163 Benzothiazine and benzothiadiazine compounds
08/07/2007US7253162 Alzheimer's disease; cognition activators; central nervous system disorders
08/07/2007US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants
08/07/2007US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other
08/07/2007US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors
08/07/2007US7252998 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
08/07/2007US7252994 Human DR4 antibodies and uses thereof
08/07/2007US7252819 Methods and compositions for correction of cardiac conduction disturbances
08/07/2007US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells
08/07/2007US7252654 Apparatus with weeping tip and method of use
08/07/2007CA2407952C Growth factor modified protein matrices for tissue engineering
08/07/2007CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties
08/07/2007CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
08/07/2007CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i)
08/07/2007CA2324001C Retinoid-like compounds for the promotion of melanin production
08/07/2007CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/07/2007CA2301799C Novel conjugates of opioids and endogenous carriers
08/07/2007CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 1564